GDRX - GoodRx Holdings, Inc.
NASDAQ
->
Healthcare
->
Health Information Services
Santa Monica,
United States
Type: Equity
GDRX price evolution
GDRX
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $672.3 | $794.9 | $761.99 | $761.08 |
| Short term investments | ||||
| Net receivables | $143.61 | $121.15 | $123.38 | $116.44 |
| Inventory | ||||
| Total current assets | $872.79 | $969.1 | $919.25 | $907.02 |
| Long term investments | ||||
| Property, plant & equipment | $45.86 | $48.38 | $51.46 | $53.68 |
| Goodwill & intangible assets | $567.11 | $593.53 | $614.25 | $609.42 |
| Total noncurrent assets | $716.01 | $738.87 | $772.85 | $704.48 |
| Total investments | ||||
| Total assets | $1588.8 | $1707.97 | $1692.1 | $1611.5 |
| Current liabilities | ||||
| Accounts payable | $36.27 | $32.91 | $6.79 | $12.39 |
| Deferred revenue | ||||
| Short long term debt | $14.96 | $10.36 | $9.76 | $8.86 |
| Total current liabilities | $122.56 | $117.82 | $82.55 | $68.98 |
| Long term debt | $696.11 | $701.12 | $704.61 | $707.05 |
| Total noncurrent liabilities | $704.28 | $708.88 | $714.18 | $715.05 |
| Total debt | $711.07 | $711.48 | $714.37 | $715.92 |
| Total liabilities | $826.84 | $826.7 | $796.73 | $784.03 |
| Shareholders' equity | ||||
| Retained earnings | -$1457.4 | -$1431.53 | -$1393.04 | -$1451.83 |
| Other shareholder equity | ||||
| Total shareholder equity | $761.96 | $881.27 | $895.37 | $827.47 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $672.3 | $757.16 | $941.11 | $971.59 |
| Short term investments | ||||
| Net receivables | $143.61 | $121.67 | $118.08 | $68.73 |
| Inventory | ||||
| Total current assets | $872.79 | $919.69 | $1088.83 | $1086.37 |
| Long term investments | ||||
| Property, plant & equipment | $45.86 | $55.73 | $49.32 | $50.77 |
| Goodwill & intangible assets | $567.11 | $602.05 | $463.47 | $317.83 |
| Total noncurrent assets | $716.01 | $684.95 | $518.8 | $383.75 |
| Total investments | ||||
| Total assets | $1588.8 | $1604.63 | $1607.63 | $1470.11 |
| Current liabilities | ||||
| Accounts payable | $36.27 | $17.7 | $17.5 | $10.29 |
| Deferred revenue | ||||
| Short long term debt | $14.96 | $11.1 | $12.88 | $11.57 |
| Total current liabilities | $122.56 | $76.32 | $81.11 | $59.55 |
| Long term debt | $696.11 | $651.8 | $689.45 | $693.36 |
| Total noncurrent liabilities | $704.28 | $713.48 | $694.83 | $699.2 |
| Total debt | $711.07 | $717.02 | $702.33 | $704.92 |
| Total liabilities | $826.84 | $789.8 | $775.95 | $758.75 |
| Shareholders' equity | ||||
| Retained earnings | -$1457.4 | -$1448.54 | -$1415.71 | -$1390.45 |
| Other shareholder equity | ||||
| Total shareholder equity | $761.96 | $814.83 | $831.68 | $711.36 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $196.64 | $179.96 | $189.68 | $183.99 |
| Cost of revenue | $15.17 | $18.72 | $16.34 | $16.7 |
| Gross Profit | $181.47 | $161.24 | $173.34 | $167.29 |
| Operating activities | ||||
| Research & development | $32.03 | $39.61 | $31.29 | $32.91 |
| Selling, general & administrative | $124.12 | $126.93 | $107.65 | $108.14 |
| Total operating expenses | $199.76 | $199.57 | $155.03 | $155.99 |
| Operating income | -$18.29 | -$38.33 | $18.31 | $11.3 |
| Income from continuing operations | ||||
| EBIT | -$9.81 | -$31.88 | $26.12 | $16.73 |
| Income tax expense | $1.23 | -$8.11 | -$46.72 | $6.89 |
| Interest expense | $14.82 | $14.72 | $14.05 | $13.13 |
| Net income | ||||
| Net income | -$25.87 | -$38.49 | $58.79 | -$3.29 |
| Income (for common shares) | -$25.87 | -$38.49 | $58.79 | -$3.29 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $750.26 | $766.55 | $745.42 | $550.7 |
| Cost of revenue | $66.92 | $65.08 | $46.72 | $29.59 |
| Gross Profit | $683.34 | $701.48 | $698.71 | $521.11 |
| Operating activities | ||||
| Research & development | $135.84 | $143.14 | $125.86 | $61.82 |
| Selling, general & administrative | $466.84 | $502.42 | $524.9 | $716.59 |
| Total operating expenses | $710.35 | $699.74 | $685.3 | $796.83 |
| Operating income | -$27.01 | $1.74 | $13.41 | -$275.72 |
| Income from continuing operations | ||||
| EBIT | $1.16 | $11.01 | $13.46 | -$275.54 |
| Income tax expense | -$46.7 | $9.6 | $15.08 | -$9.83 |
| Interest expense | $56.73 | $34.24 | $23.64 | $27.91 |
| Net income | ||||
| Net income | -$8.87 | -$32.83 | -$25.25 | -$293.62 |
| Income (for common shares) | -$8.87 | -$32.83 | -$25.25 | -$293.62 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$25.87 | -$38.49 | $58.79 | -$3.29 |
| Operating activities | ||||
| Depreciation | $44.69 | $33.99 | $17.11 | $15.98 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $28.78 | $32.65 | $17.9 | $25.5 |
| Total cash flows from operations | $15.87 | $60.27 | $29.87 | $32.29 |
| Investing activities | ||||
| Capital expenditures | -$12.87 | -$13.65 | -$14.96 | -$14.29 |
| Investments | ||||
| Total cash flows from investing | -$12.87 | -$13.65 | -$14.96 | -$14.29 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$75.53 | -$4.59 | -$7.71 | -$8.81 |
| Net borrowings | $0 | -$1.76 | -$1.76 | -$1.76 |
| Total cash flows from financing | -$125.61 | -$13.71 | -$13.99 | -$14.09 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$122.61 | $32.92 | $0.91 | $3.91 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$8.87 | -$32.83 | -$25.25 | -$293.62 |
| Operating activities | ||||
| Depreciation | $111.77 | $57.53 | $37.64 | $22.91 |
| Business acquisitions & disposals | -$155.28 | -$144.28 | -$55.79 | |
| Stock-based compensation | $104.82 | $120.23 | $160.46 | $397.29 |
| Total cash flows from operations | $138.29 | $146.78 | $178.78 | $131.34 |
| Investing activities | ||||
| Capital expenditures | -$55.77 | -$55.21 | -$34.46 | -$35.82 |
| Investments | ||||
| Total cash flows from investing | -$55.77 | -$210.5 | -$178.73 | -$91.62 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$96.64 | -$92.56 | $35.02 | $997.8 |
| Net borrowings | -$5.27 | -$7.03 | -$7.03 | -$8.34 |
| Total cash flows from financing | -$167.4 | -$120.23 | -$30.53 | $905.82 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$84.87 | -$183.94 | -$30.48 | $945.54 |
News
Fundamentals
| Market cap | $2.65B |
|---|---|
| Enterprise value | $2.69B |
| Shares outstanding | 394.09M |
| Revenue | $750.26M |
|---|---|
| EBITDA | $112.93M |
| EBIT | $1.16M |
| Net Income | -$8.87M |
| Revenue Q/Q | 6.81% |
| Revenue Y/Y | -2.12% |
| P/E ratio | -299.08 |
|---|---|
| EV/Sales | 3.59 |
| EV/EBITDA | 23.83 |
| EV/EBIT | 2.33K |
| P/S ratio | 3.54 |
| P/B ratio | 3.48 |
| Book/Share | 1.93 |
| Cash/Share | 1.71 |
| EPS | -$0.02 |
|---|---|
| ROA | -0.54% |
| ROE | -1.05% |
| Debt/Equity | 1.09 |
|---|---|
| Net debt/EBITDA | 1.37 |
| Current ratio | 7.12 |
| Quick ratio | 7.12 |